Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2004
02/12/2004WO2003066646A3 Macrocyclic module compositions
02/12/2004WO2003049702A3 Vanilloid receptor ligands and their use in treatments
02/12/2004WO2003020700A3 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
02/12/2004US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
02/12/2004US20040030134 Bone disorders; osteoporosis
02/12/2004US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
02/12/2004US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders
02/12/2004US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
02/12/2004US20040029915 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
02/12/2004US20040029911 Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands
02/12/2004US20040029909 Heat, sulfurization of the corresponding compound with tetraphosphorus tetrasulfide; Parkinson's disease, sexual disorders
02/12/2004US20040029884 Cyclization in presence of Lawesson's reagent
02/12/2004US20040029882 Antimicrobial quinolones, their compositions and uses
02/12/2004US20040029879 Viricides for herpes virus
02/12/2004US20040029877 Immune response induction; viricides; anticancer agents
02/12/2004US20040029859 Compounds useful in therapy
02/12/2004US20040029857 Anticancer agents; central nervous system disorders; antiinflamamtory agents
02/12/2004US20040029835 Antitumor agents
02/12/2004US20040029745 Wear resistance; oil additive
02/12/2004US20040029734 Fused-benzene derivatives useful as herbicides
02/12/2004US20040028673 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders
02/11/2004EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
02/11/2004EP1387833A1 Protease-inhibitors
02/11/2004EP1387688A2 Benzazepinone alpha v integrin receptor antagonists
02/11/2004EP1387686A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection
02/11/2004EP1387681A2 Antiviral compounds
02/11/2004EP1387679A1 Sulfonamides
02/11/2004EP1387612A1 Pyridinyl fused bicyclic amide as fungicides
02/11/2004CN1474819A Novel imidazole derivatives, production method thereof and use thereof
02/11/2004CN1474703A Taxoid conjugates as antimitotic and antitumor agents
02/11/2004CN1474692A Treatment of premature ejaculation
02/11/2004CN1474651A Use of riboflavin and flavin derivatives as chitinase inhibitors
02/11/2004CN1137891C Process for preparing growth hormone cinogenic agent
02/11/2004CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
02/10/2004US6689887 Perylenetetracarboxylic acid diimides and carbocyanines
02/10/2004US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones
02/10/2004US6689808 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them
02/10/2004US6689790 Substituted triazolopyridine compounds
02/10/2004US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
02/10/2004US6689773 Uracil substituted phenyl sulfamoyl carboxamides
02/10/2004US6689384 Stable pergolide mesylate and process for making same
02/10/2004CA2297134C A novel process for preparing intermediates or inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
02/05/2004WO2004011468A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
02/05/2004WO2004011466A1 NOVEL PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVE
02/05/2004WO2004011463A1 Modified pictet-spengler reaction and products prepared therefrom
02/05/2004WO2004011462A1 Preparation of 1h-imidazo [4,5-c] quinolin-4-amines via novel 1h-imidazo [4,5-c] quinolin-4-cyano and 1h-imidazo [4,5-c] quinolin-4-carboxamide intermediates
02/05/2004WO2004011436A1 Quinoline derivatives and their use as mycobacterial inhibitors
02/05/2004WO2004011425A2 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives
02/05/2004WO2004010981A1 Methods and dosage forms for controlled delivery of paliperidone
02/05/2004WO2003097644A3 Non-nucleoside reverse transcriptase inhibitors
02/05/2004WO2003080608A3 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
02/05/2004WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa
02/05/2004US20040024210 New compounds
02/05/2004US20040024208 Cyclic protein tyrosine kinase inhibitors
02/05/2004US20040024190 Viral polymerase inhibitors
02/05/2004US20040024151 Functionalized perylene tetracarboxylic acid diimides
02/05/2004US20040024067 Deacetylase inhibitors
02/05/2004US20040024010 3-methylidenyl-2-indolinone modulators of protein kinase
02/05/2004US20040024008 Such as N-(4-hydroxyphenyl)-3-(6-methyl-3-oxo-4-(3-(trifluoromethyl)phenyl)-3,6 -dihydrodipyrazolo(3,4-b:3,4-d)pyr idin-2(1H)-yl)benzamide for treating automimmune diseases, graft versus host disease, and multiple sclerosis
02/05/2004US20040024002 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
02/05/2004US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
02/05/2004US20040023995 Pyridopyrimidine compounds and their uses
02/05/2004US20040023993 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba)
02/05/2004US20040023982 Antiviral azaindole derivatives
02/05/2004US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
02/05/2004US20040023972 Use of substituted imidazo[1,2-a]-pyridin-, -pyrimidin-and-pyrazin-3-yl-amine derivatives in the preparation of medicaments for inhibiting NOS
02/05/2004US20040023970 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I
02/05/2004US20040023965 Corticotropin releasing factor antagonists imidazo-triazines of formula I:
02/05/2004US20040023955 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
02/05/2004US20040023947 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/05/2004US20040023946 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
02/05/2004US20040023932 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the
02/05/2004US20040023927 Bicyclic imidazo-5-yl-amine derivatives
02/05/2004US20040023843 Treatment of an emotional disorder, which contains the NK-1 receptor antagonist having particular properties of (1) having no serotonin uptake inhibitory effect, (2) being capable of migrating into the hypothalamus, or (3) having an
02/05/2004US20040023290 Novel therapeutic agents that modulate enzymatic processes
02/05/2004US20040023060 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties
02/05/2004US20040022737 Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
02/05/2004US20040021204 Heteroatom-containing diamondoid transistors
02/05/2004DE10232572A1 Neue 2,5-disubstituierte Pyrimidinderivate New 2,5-disubstituted pyrimidine derivatives
02/05/2004DE10232571A1 4-Aminosubstituierte Pyrimidinderivate 4-Amino-substituted pyrimidine derivatives
02/05/2004CA2493158A1 Preparation of 1h-imidazo [4,5-c] quinolin-4-amines via novel 1h-imidazo [4,5-c] quinolin-4-cyano and 1h-imidazo [4,5-c] quinolin-4-carboxamide intermediates
02/05/2004CA2489165A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
02/04/2004EP1386912A1 Cyclic amidine derivative
02/04/2004EP1385854A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
02/04/2004EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors
02/04/2004EP1385847A2 Pyrazolo[1,5-a]pyridine derivatives
02/04/2004EP1385845A1 N-aroyl cyclic amines
02/04/2004EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
02/04/2004EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
02/04/2004EP1385824A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
02/04/2004EP1385515A1 Spiropyrazole compounds
02/04/2004EP1385513A1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents
02/04/2004EP1385512A2 Use of pyridoindolone derivatives for preparing anticancer medicines
02/04/2004EP1385504A1 Method of inhibiting adhesion formation
02/04/2004EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
02/04/2004EP1385459A2 Transdermal delivery of pergolide
02/04/2004EP1228147B1 Dye labeled imidazoquinoline compounds
02/04/2004EP1196409B1 Respiratory syncytial virus replication inhibitors
02/04/2004CN1473162A Bicyclic triazolone derivatives and herbicides containing the same
02/04/2004CN1473161A Pyrazole compounds as protein kinase inhibitors